lymphokine activated killer cells
Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.
7
Celecoxib increases lung cancer cell lysis by lymphokine- activated killer cells via upregulation of ICAM-1
15
Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine activated killer cells
9
Characterization of cytotoxic cells from reovirus-infected SCID mice: activated cells express natural killer- and lymphokine-activated killer-like activity but fail to clear infection.
5
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
11
Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
13
Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.
7
The Natural Killer Cell: A Historical Perspective and the Use of Supplements to Enhance NKC Activity
32
Natural Killer Cell Immunodeficiency in Siblings: Defective Killing in the Absence of Natural Killer Cytotoxic Factor Activity in Natural Killer and Lymphokine-Activated Killer Cytotoxicities
10
Role of human natural killer cells in health and disease.
9
Enhancement of natural killer function through activation of the T11 E rosette receptor
5
Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
11
Natural killer cells: role in local tumor growth and metastasis
10
The role of nonspecific cytotoxic cells and cytokine production in the pathogenesis of human intestinal diseases
327
Pulmonary manifestations in Behçet disease: impaired natural killer cells activity
8
Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
15
Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD)
9
Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells.
11
Natural killer cells and natural killer T cells in Lyme arthritis
11
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
16